Literature DB >> 33936995

Specimen number based diagnostic yields of suspicious axillary lymph nodes in core biopsy in breast cancer: clinical implications from a prospective exploratory study.

Yue Hu1,2, Jingsi Mei1,2, Yaping Yang1,2, Ran Gu1,2, Jiajie Zhong3, Xiaofang Jiang1,2, Fengtao Liu1,2, Juanjuan Yong3, Hongli Wang1,2, Shiyu Shen1,2, Jing Liang1,2, Qiang Liu1,2, Chang Gong1,2,4.   

Abstract

BACKGROUND: Ultrasound (US)-guided core needle biopsy (CNB) is widely applied in the pathological diagnosis of suspicious axillary lymph nodes (ALNs) in breast cancer. However, the number of specimens removed during biopsy is currently based on the preference of the individual radiologist. This study aims to analyze the specimen number based diagnostic yields of US guided CNB of suspicious ALNs in breast cancer.
METHODS: Core biopsy specimens of suspicious lymph nodes were prospectively obtained from breast cancer patients treated at our hospital between November, 2018, and July, 2019. Four specimens were obtained from each patient and labeled 1-4 in the order they were removed. Each specimen underwent pathological evaluation to determine whether metastasis had occurred. The diagnostic yields of the specimens were calculated and differences in diagnostic accuracy according to the number of specimens were evaluated by McNemar's test.
RESULTS: A total of 167 patients were enrolled, and 139 (83.2%) cases were identified as metastasis by CNB. The diagnostic yields were: 74.2% (specimen 1), 87.8% (specimens 1-2), 91.2% (specimens 1-3), and 94.6% (specimens 1-4). The increases in diagnostic yield from specimen 1 to 1-2 and from specimens 1-2 to 1-4 were significant; however, no significant differences were detected between specimens 1-3 and the first two, or between specimens 1-4 and the first three in this sample size. The lower diagnostic abilities for the first two specimens were associated with shorter long- and short-axis lengths of lymph nodes on US.
CONCLUSIONS: Although the second specimen contributed significant diagnostic yield of suspicious axillary lymph nodes in core biopsy in breast cancer, a minimum number cannot be determined by this study. Additional specimens may improve diagnostic yield particularly in patients with small nodes. 2021 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Breast cancer; axillary lymph node (ALN); core needle biopsy (CNB); specimen; ultrasound (US)

Year:  2021        PMID: 33936995      PMCID: PMC8047355          DOI: 10.21037/qims-20-1030

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  29 in total

1.  American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.

Authors:  Gary H Lyman; Armando E Giuliano; Mark R Somerfield; Al B Benson; Diane C Bodurka; Harold J Burstein; Alistair J Cochran; Hiram S Cody; Stephen B Edge; Sharon Galper; James A Hayman; Theodore Y Kim; Cheryl L Perkins; Donald A Podoloff; Visa Haran Sivasubramaniam; Roderick R Turner; Richard Wahl; Donald L Weaver; Antonio C Wolff; Eric P Winer
Journal:  J Clin Oncol       Date:  2005-09-12       Impact factor: 44.544

2.  Ultrasound elastography as an adjuvant to conventional ultrasound in the preoperative assessment of axillary lymph nodes in suspected breast cancer: a pilot study.

Authors:  K Taylor; S O'Keeffe; P D Britton; M G Wallis; G M Treece; J Housden; D Parashar; S Bond; R Sinnatamby
Journal:  Clin Radiol       Date:  2011-08-11       Impact factor: 2.350

3.  Axillary lymph node core biopsy for breast cancer metastases -- how many needle passes are enough?

Authors:  E J Macaskill; C A Purdie; L B Jordan; D Mclean; P Whelehan; D C Brown; A Evans
Journal:  Clin Radiol       Date:  2011-11-26       Impact factor: 2.350

4.  Diagnostic strategy for the assessment of axillary lymph node status in breast cancer.

Authors:  F Maxwell; C de Margerie Mellon; M Bricout; E Cauderlier; M Chapelier; M Albiter; P Bourrier; M Espié; E de Kerviler; C de Bazelaire
Journal:  Diagn Interv Imaging       Date:  2015-09-12       Impact factor: 4.026

Review 5.  To do or not to do: axillary nodal evaluation after ACOSOG Z0011 Trial.

Authors:  Kathryn L Humphrey; Mansi A Saksena; Phoebe E Freer; Barbara L Smith; Elizabeth A Rafferty
Journal:  Radiographics       Date:  2014 Nov-Dec       Impact factor: 5.333

6.  Preoperative ultrasound-guided needle biopsy of axillary nodes in invasive breast cancer: meta-analysis of its accuracy and utility in staging the axilla.

Authors:  Nehmat Houssami; Stefano Ciatto; Robin M Turner; Hiram S Cody; Petra Macaskill
Journal:  Ann Surg       Date:  2011-08       Impact factor: 12.969

7.  Cost modeling of preoperative axillary ultrasound and fine-needle aspiration to guide surgery for invasive breast cancer.

Authors:  Judy C Boughey; James P Moriarty; Amy C Degnim; Melissa S Gregg; Jason S Egginton; Kirsten Hall Long
Journal:  Ann Surg Oncol       Date:  2010-02-02       Impact factor: 5.344

8.  Ultrasound guided percutaneous axillary lymph node core biopsy: how often is the sentinel lymph node being biopsied?

Authors:  P D Britton; E Provenzano; S Barter; M Gaskarth; A Goud; P Moyle; R Sinnatamby; M Wallis; J R Benson; P Forouhi; G C Wishart
Journal:  Breast       Date:  2008-11-07       Impact factor: 4.380

9.  Bone and soft-tissue lesions: what factors affect diagnostic yield of image-guided core-needle biopsy?

Authors:  Jim S Wu; Jeffrey D Goldsmith; Perry J Horwich; Sanjay K Shetty; Mary G Hochman
Journal:  Radiology       Date:  2008-09       Impact factor: 11.105

10.  Ultrasound-guided large-core needle biopsies of breast lesions: analysis of 962 cases to determine the number of samples for reliable tumour classification.

Authors:  G Sauer; H Deissler; K Strunz; G Helms; E Remmel; K Koretz; R Terinde; R Kreienberg
Journal:  Br J Cancer       Date:  2005-01-31       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.